Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$12.56 - $22.53 $18,714 - $33,569
1,490 Added 3.58%
43,112 $553,000
Q2 2022

Aug 12, 2022

BUY
$10.36 - $23.93 $418,875 - $967,537
40,432 Added 3397.65%
41,622 $550,000
Q1 2022

May 16, 2022

BUY
$17.19 - $26.1 $20,456 - $31,059
1,190 New
1,190 $25,000
Q4 2021

Feb 11, 2022

SELL
$18.11 - $30.72 $23,434 - $39,751
-1,294 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$30.53 - $41.09 $133,110 - $179,152
-4,360 Reduced 77.11%
1,294 $44,000
Q1 2021

May 12, 2021

SELL
$36.08 - $69.81 $31,497 - $60,944
-873 Reduced 13.38%
5,654 $220,000
Q3 2020

Nov 12, 2020

BUY
$22.23 - $37.48 $54,263 - $91,488
2,441 Added 59.74%
6,527 $219,000
Q1 2020

May 11, 2020

SELL
$16.8 - $34.15 $83,781 - $170,306
-4,987 Reduced 54.97%
4,086 $94,000
Q4 2019

Feb 14, 2020

BUY
$20.01 - $30.79 $181,550 - $279,357
9,073 New
9,073 $256,000

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $386M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.